Clinical trials
Phase 1/2 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
262 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 13 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 4 |
| 2012 | 8 |
| 2013 | 14 |
| 2014 | 10 |
| 2015 | 13 |
| 2016 | 11 |
| 2017 | 21 |
| 2018 | 10 |
| 2019 | 18 |
| 2020 | 24 |
| 2021 | 19 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 15 |
| 2025 | 20 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Recruiting | 46 |
| Terminated | 37 |
| Active, not recruiting | 30 |
| Unknown status | 22 |
| Withdrawn | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Aarhus | 18 |
| Rigshospitalet, Denmark | 13 |
| Genmab | 11 |
| Novartis Pharmaceuticals | 11 |
| Hoffmann-La Roche | 10 |
| Inge Marie Svane | 9 |
| Herlev Hospital | 8 |
| Bristol-Myers Squibb | 7 |
| Merck Sharp & Dohme LLC | 6 |
| Odense University Hospital | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 22 |
| Neoplasms | 19 |
| Recurrence | 14 |
| Breast Neoplasms | 13 |
| Ovarian Neoplasms | 13 |
| Colorectal Neoplasms | 11 |
| Melanoma | 11 |
| Multiple Myeloma | 9 |
| Endometrial Neoplasms | 8 |
| Lung Neoplasms | 8 |
Trials
Showing 51 to 75 of 262. Each trial links to its page on Pharma Observatory.
162 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.